-
1
-
-
84855306129
-
Potentiation of triclabendazole action in vivo against a triclabendazoleresistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole
-
Devine C, Brennan GP, Lanusse CE, Alvarez LI, Trudgett A, Hoey E, et al. Potentiation of triclabendazole action in vivo against a triclabendazoleresistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole. Vet Parasitol. 2012;184:37-47. http://dx.doi.org/10.1016/j.vetpar.2011.08.006
-
(2012)
Vet Parasitol
, vol.184
, pp. 37-47
-
-
Devine, C.1
Brennan, G.P.2
Lanusse, C.E.3
Alvarez, L.I.4
Trudgett, A.5
Hoey, E.6
-
2
-
-
84861203929
-
Fascioliasis
-
Heymann DL, editor, 19th ed. Washington (DC): American Public Health Association
-
Eberhard M, Engels D. Fascioliasis. In: Heymann DL, editor. Control of communicable diseases manual, 19th ed. Washington (DC): American Public Health Association; 2008. p. 230-1.
-
(2008)
Control of Communicable Diseases Manual
, pp. 230-231
-
-
Eberhard, M.1
Engels, D.2
-
3
-
-
67650526854
-
Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control
-
Mas-Coma S, Valero MA, Bargues MD. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol. 2009;69:41-146. http://dx.doi.org/10.1016/S0065-308X(09)69002-3
-
(2009)
Adv Parasitol
, vol.69
, pp. 41-146
-
-
Mas-Coma, S.1
Valero, M.A.2
Bargues, M.D.3
-
6
-
-
28644450281
-
Triclabendazole for the treatment of fascioliasis and paragonimiasis
-
Keiser J, Engels D, Buscher G, Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs. 2005;14:1513-26. http://dx.doi.org/10.1517/13543784.14.12.1513
-
(2005)
Expert Opin Investig Drugs
, vol.14
, pp. 1513-1526
-
-
Keiser, J.1
Engels, D.2
Buscher, G.3
Utzinger, J.4
-
7
-
-
79956370340
-
Reducing the future threat from (liver) fluke: Realistic prospect or quixotic fantasy?
-
Fairweather I. Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy? Vet Parasitol. 2011;180:133-43. http://dx.doi.org/10.1016/j.vetpar.2011.05.034
-
(2011)
Vet Parasitol
, vol.180
, pp. 133-143
-
-
Fairweather, I.1
-
8
-
-
0034710375
-
Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in the Netherlands
-
Moll L, Gaasenbeek CPH, Vellema P, Borgsteede FHM. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in the Netherlands. Vet Parasitol. 2000;91: 153-8. http://dx.doi.org/10.1016/S0304-4017(00)00267-3
-
(2000)
Vet Parasitol
, vol.91
, pp. 153-158
-
-
Moll, L.1
Gaasenbeek, C.P.H.2
Vellema, P.3
Borgsteede, F.H.M.4
-
9
-
-
0035808830
-
An experimental study on triclabendazole resistance of Fasciola hepatica in sheep
-
Gaasenbeek CPH, Moll L, Cornelissen JBWJ, Vellema P, Borgsteede FHM. An experimental study on triclabendazole resistance of Fasciola hepatica in sheep. Vet Parasitol. 2001;95:37-43. http://dx.doi.org/10.1016/S0304-4017(00)00413-1
-
(2001)
Vet Parasitol
, vol.95
, pp. 37-43
-
-
Gaasenbeek, C.P.H.1
Moll, L.2
Cornelissen, J.B.W.J.3
Vellema, P.4
Borgsteede, F.H.M.5
|